Phase II Study of Daily Oral VP-16 in Previously Untreated Melanoma

Abstracts/Posters/Presentations:

• Whittaker T, Schultz S, Rynard S: Phase II Study of Daily Oral VP-16 in Metastatic Melanoma: A Hoosier Oncology Group Study MEL89-1. Proc Am Soc Clin Oncol, 1992.